Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

241 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
Castera L. Castera L. Semin Liver Dis. 2015 Aug;35(3):291-303. doi: 10.1055/s-0035-1562948. Epub 2015 Sep 17. Semin Liver Dis. 2015. PMID: 26378645 Review.
[Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit].
Castera L, Pauwels A, Lévy VG. Castera L, et al. Gastroenterol Clin Biol. 1996;20(3):263-8. Gastroenterol Clin Biol. 1996. PMID: 8763065 French.

Two prognostic indicators were defined: shock requiring the administration of vasoactive drugs, and the presence of 3 out of the 4 following predictive factors: grade III or IV encephalopathy, mechanical ventilation, prothrombin index < 30%, and serum creatinine > 130 mumol

Two prognostic indicators were defined: shock requiring the administration of vasoactive drugs, and the presence of 3 out of the 4 following …
Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis.
Castera L, Hartmann DJ, Chapel F, Guettier C, Mall F, Lons T, Richardet JP, Grimbert S, Morassi O, Beaugrand M, Trinchet JC. Castera L, et al. J Hepatol. 2000 Mar;32(3):412-8. doi: 10.1016/s0168-8278(00)80391-8. J Hepatol. 2000. PMID: 10735610
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
Castéra L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani ES, Pawlotsky JM, Dhumeaux D. Castéra L, et al. Gut. 2003 Feb;52(2):288-92. doi: 10.1136/gut.52.2.288. Gut. 2003. PMID: 12524415 Free PMC article.
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, Pawlotsky JM, Dhumeaux D. Castéra L, et al. Gut. 2004 Mar;53(3):420-4. doi: 10.1136/gut.2002.009936. Gut. 2004. PMID: 14960527 Free PMC article.
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V. Castéra L, et al. Gastroenterology. 2005 Feb;128(2):343-50. doi: 10.1053/j.gastro.2004.11.018. Gastroenterology. 2005. PMID: 15685546
Hepatitis C virus-induced hepatocellular steatosis.
Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Castera L, et al. Am J Gastroenterol. 2005 Mar;100(3):711-5. doi: 10.1111/j.1572-0241.2005.40898.x. Am J Gastroenterol. 2005. PMID: 15743372 Review.
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.
Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Lédinghen V. Foucher J, et al. Among authors: castera l. Gut. 2006 Mar;55(3):403-8. doi: 10.1136/gut.2005.069153. Epub 2005 Jul 14. Gut. 2006. PMID: 16020491 Free PMC article.
Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations.
Foucher J, Castéra L, Bernard PH, Adhoute X, Laharie D, Bertet J, Couzigou P, de Lédinghen V. Foucher J, et al. Among authors: castera l. Eur J Gastroenterol Hepatol. 2006 Apr;18(4):411-2. doi: 10.1097/00042737-200604000-00015. Eur J Gastroenterol Hepatol. 2006. PMID: 16538113
Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L. Castera L. Minerva Gastroenterol Dietol. 2006 Jun;52(2):125-34. Minerva Gastroenterol Dietol. 2006. PMID: 16557184 Review.
241 results
Jump to page
Feedback